banner
Reference Listed Drugs
MabThera 100mg/10ml 500mg/50ml Rituximab Injection Reference Listed Drug

MabThera 100mg/10ml 500mg/50ml Rituximab Injection Reference Listed Drug

MabThera is indicated for the treatment of relapsed or chemotherapy-resistant intolerant B-cell non-Hodgkin lymphoma. For R&D purposes only.

Product Details

* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.

 

Generic name Rituximab Injection
Trade name MabThera
Specification

100mg/10ml

500mg/50ml

Main ingredients

Active ingredients:Rituximab.

In addition to the active ingredient, this medicine contains the following inactive ingredients: sodium citrate, polysorbate 80, sodium chloride and water for injection

Appearance This product is colorless or light yellow clear liquid, no foreign matter, flocculent and precipitation.
MA Holder Roche Pharma(Schweiz)AG
Manufacturer Roche Diagnostics GmbH

 

 

Indications:

MabThera is indicated for the treatment of relapsed or chemotherapy-resistant intolerant B-cell non-Hodgkin lymphoma.
Ease recurrence or resistant follicular symptoms of central type of lymphoma.
Alleviate the CD20 positive II - IV follicular symptoms of non-hodgkin's lymphoma.
Ease the CD20 positive symptoms of diffuse large B cell non-hodgkin's lymphoma.

 

 

MabThera-1

 

MabThera-2

 

MabThera-3

 

 

For more details,pls contact Janney:

Email: tosun-global@upharm.cn

Wechat/Whatsapp:(+86)18922120575

 

 

Hot Tags: MabThera 100mg/10ml 500mg/50ml Rituximab Injection Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, AdapaleneGel, Adefovir Dipivoxil Tablets, Esomeprazole Magnesium Enteric Coated Capsules, Agomelatine Tablets, Reference Listed Drugs, Alfacalcidol Soft Capsules

Send Inquiry
Verification Code: